Thorne HealthTech, Inc. (NASDAQ:THRN) Q1 2023 Earnings Conference Call May 11, 2023 5:30 PM ET

Company Participants

Thomas Wilson - VP, IR

Paul Jacobson - CEO

Saloni Varma - CFO

Tom McKenna - COO

Michelle Crow - CMO

Conference Call Participants

Sean Dodge - RBC

Elizabeth Anderson - Evercore

Susan Anderson - Canaccord

Steven Mah - TD Cowen

Operator

Good afternoon. Thank you for attending today's Thorne HealthTech, Inc. First Quarter 2020 Earnings Call. My name is Hannah, and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions].

I would now like to pass the conference over to our host, Thomas Wilson, VP of Investor Relations. You may go ahead.

Thomas Wilson

Good afternoon, everyone. Thank you for joining Thorne HealthTech's First Quarter 2023 Earnings Call. With me today are Paul Jacobson, our CEO; Saloni Varma, our CFO; Tom McKenna, our COO; and Michelle Crow, our CMO, are also available for questions.

Before we begin, please note that today's discussion contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those indicated by our forward-looking statements. More information about potential risk factors can be found in our 2022 annual report on Form 10-K and our upcoming Form 10-Q, which we anticipate filing in the next couple of days and in other SEC filings.

Today, in addition to U.S. GAAP reporting, we will be discussing financial measures that do not conform to GAAP. We believe these non-GAAP measures enhance the understanding of our performance because they are more representative of how we internally measure the business. Non-GAAP financial measures should not be considered in isolation from or as a substitute for GAAP measures. A reconciliation of GAAP to non-GAAP results is available in the earnings press release we issued after market closed yesterday and in the supplemental Investor Presentation posted to our IR website.

Finally, next week, we will be participating in the RBC Capital Markets Global Healthcare Conference in New York and holding investor meetings. Webcast and the conference will be available on our IR website, and we look forward to meeting with you.

With that, I'll turn the call over to Paul.

Paul Jacobson

Good afternoon. Thanks, everyone, for joining the call.

Today, I'll provide a brief strategic overview of Thorne's unique positioning and first-mover advantage in the growing field of personalized scientific wellness and how our strategy puts us on a pathway of sustainable value creation for our shareholders. I'll then discuss key accomplishments during the quarter and then review our progress in our core growth strategies, including key pipeline programs and key milestones we expect to achieve in 2023. I'll then touch on our first quarter financial results and outlook for the rest of the year. And finally, Saloni will provide a detailed review of our first quarter 2023 financials. As Thomas mentioned, additional details can be found in the earnings release and investor supplement issued after the market closed.